What we publish
Each piece has a label at the top. Here is what each one is for, when we publish it and how often it changes.
| Type | Answers | Published | Updated |
|---|---|---|---|
| Daily move | Why did it move today? | Same day | If facts change |
| Trend | Why so much, over months? | After a long move | If the story moves |
| Explainer | What do we know so far? | While it unfolds | As it develops |
| Market | Why did the market move? | Big index days | Rarely |
| Big Picture | What is the theme behind it? | When a theme hits many | With new data |
| Quarterly review | Did the story change? | After each quarterly filing | New review after each filing |
| The Long View | What do the filings say? | Covered companies | After quarterly and annual filings |
| Our View | What do we think, and why? | Occasionally | If assumptions change |
| The Full Story | How did this stock get here? | Occasionally | With new chapters |
| Blog | How do we work? | Occasionally | Rarely |
Daily move Down 12%
Why a stock jumped or fell today.
- When
- The same day, when company news causes a sharp move beyond the wider market or sector, and the news or reaction needs explaining.
- What’s in it
- A 30-second answer, what happened, why the market reacted that way, whether it changes the longer-term story, and the sources.
- Updates
- When important new facts come out, with a dated note.
Big gains · Big drops · Example: Gap jumps 12% even as it cuts its full-year outlook (Nov 20, 2026)
TrendTREND
Why a stock is down or up so much over weeks or months.
- When
- After a long, large fall or rise that readers keep asking about.
- What’s in it
- A price chart with key events, the main reasons for the move, comparisons with past valuations and similar companies, and an outlook drawn from analysts and other named sources.
- Updates
- When the story moves, with a dated note.
All trends · Example: SAP up 60% since July as its cloud backlog defies the AI scare (Nov 17, 2026)
ExplainerEXPLAINER
The story so far on a company’s developing situation, such as a takeover, a clinical trial or a lawsuit—even without a large stock move.
- When
- While a situation unfolds over days or weeks.
- What’s in it
- What is confirmed, what is only reported and what is not known, the background that matters, and what to watch, with dates.
- Updates
- Dated updates appear newest first. The page is marked DEVELOPING while the situation unfolds; the tag is removed when it settles.
All explainers · Example: Anthropic closes 17% above its IPO price after opening 34% higher in its Nasdaq debut (Nov 19, 2026)
MarketMARKET
Why a whole market, country or sector moved.
- When
- On big days for an index or a sector.
- What’s in it
- What moved, the causes and the stocks hit hardest.
- Updates
- Rarely; with a dated note if needed.
All market moves · Example: Chip stocks fall 9% as doubts over AI's payoff and Nvidia's turmoil deepen (Nov 20, 2026)
Big PictureBIG PICTURE
Themes that move many stocks at once, and the mechanics behind them.
- When
- When one theme drives a group of stocks.
- What’s in it
- A deeper look at the numbers and the knock-on effects, and the companies involved.
- Updates
- When new data changes the picture.
All Big Picture · Example: The driver goes, the car stays: what robotaxis would reprice, from insurance to gas pumps (Nov 20, 2026)
Quarterly reviewQUARTERLY REVIEW
Did the story change after the latest results?
- When
- After each quarterly filing, for every company with a Long View.
- What’s in it
- A one-line verdict, a table of what got better or worse against the last quarter and management’s own guidance, what to watch, and a link to the Long View.
- Updates
- Each quarter gets a new review. Errors get a dated correction or update note.
All quarterly reviews · Example: Nvidia Q3 2027: a $130 billion guide and a raised outlook in first report without Huang (Nov 17, 2026)
The Long ViewTHE LONG VIEW
A facts-only, living record from the company’s filings: the story so far, dilution and cash runway. It is not an article.
- When
- One per company we follow closely.
- What’s in it
- What the business does, its history and latest results, whether share buybacks offset newly issued shares, how reported profit compares with cash generated, reliance on major customers, and upcoming events. No opinions and no forecasts.
- Updates
- After every quarterly and annual filing.
All Long Views · Example: Corcept Therapeutics: The Long View
Our ViewOUR VIEW · OPINION
Our analysis of a company and our scenarios for 2030, based on stated assumptions. It is not advice.
- When
- Occasionally, for companies we have studied in depth.
- What’s in it
- Our argument, the facts it rests on, the other side, scenarios with probabilities from our model, and what would change our mind.
- Updates
- When our assumptions change; the date is shown.
All Our View pieces · Example: Moderna: what today's price assumes about its cancer platform (Nov 17, 2026)
How to read the scenarios
We run our model thousands of times with different assumptions for growth, profit margins and valuation. P10 is the result that 10% of runs fall below. P50 is the middle result: half fall below and half above. P90 is the result that 90% fall below. The P10–P90 range contains the middle 80% of results, not every possible outcome. A probability of 60% means an outcome occurred in 60 out of 100 model runs. It is a model estimate, not a known real-world chance or a promise. The results depend on assumptions that can change or be wrong. Actual outcomes may fall outside the range, and the model may miss important risks.The Full StoryTHE FULL STORY
One stock's whole story, from its listing to today, told as a narrative around one long price chart.
- When
- Occasionally, for a stock whose history helps explain where it stands now.
- What’s in it
- A chapter for each turning point, built from filings, court and regulator records and the company's own statements, with the share price on the days the news arrived; charts of the numbers behind each turn; and what the record suggests to watch. Other outlets' reporting is attributed. No forecasts and no investment advice.
- Updates
- When a new chapter begins, with a dated update at the top. Errors get a dated correction or update note.
All Full Story pieces · Example: Summit Therapeutics: One Man, One Drug and a $500 Million Check (Nov 19, 2026)
BlogBLOG
Occasional posts about investing and how we work: our methods, our checks and the mistakes we fixed. Not about one stock's move.
- When
- Once in a while, with no fixed schedule.
- What’s in it
- Plain-English explanations of how we do things and what we learned, with sources for factual claims. Never buy or sell advice.
- Updates
- Rarely; the date is shown if a post changes.
All blog posts · Example: How our valuation model works: from company filings to a range of outcomes (Oct 30, 2026)
Every piece is information, not investment advice. See how we write and check articles.